Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patients

PURPOSE: Recently, docetaxel treatment of metastatic prostate cancer patients shifted towards the hormone-sensitive stage of the disease. There are contradictive reports on differences in toxicity of docetaxel in metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermunt, Marit A. C., van Nuland, Merel, van der Heijden, Lisa T., Rosing, Hilde, Beijnen, Jos. H., Bergman, Andries M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135852/
https://www.ncbi.nlm.nih.gov/pubmed/35467095
http://dx.doi.org/10.1007/s00280-022-04433-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135852/
https://www.ncbi.nlm.nih.gov/pubmed/35467095
http://dx.doi.org/10.1007/s00280-022-04433-3

Ejemplares similares